Read More Pharma Industry News Can Galmed Pharmaceuticals avoid delisting? Nasdaq compliance clock is ticking Nasdaq has notified Galmed Pharmaceuticals of a share price deficiency. Find out what this means for investors and the company's future strategy. byPallavi MadhirajuJanuary 31, 2026